|
VIDI assistant member Dr. Holly Janes wants to use new statistical methods to help investigators focus their efforts on developing the best biomarkers. Read more. |
VIDI scientists are working to develop new techniques to rapidly detect strains of novel H1N1 with resistance to oseltamivir, the common antiviral drug. Read more. |
Each newsletter features summaries of original research articles published in the previous month where VIDI scientists are either the primary or last author, and links to review articles and other articles with VIDI authors.
VIDI Vitals is published monthly by Rachel Tompa, editor-in-chief, 1616 Eastlake Avenue, Seattle, WA, 98109. Ideas, suggestions, and submissions for future issues can be sent to Rachel.
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.
